1. Home
  2. STKH vs LSTA Comparison

STKH vs LSTA Comparison

Compare STKH & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STKH
  • LSTA
  • Stock Information
  • Founded
  • STKH 2018
  • LSTA 1980
  • Country
  • STKH Israel
  • LSTA United States
  • Employees
  • STKH 24
  • LSTA N/A
  • Industry
  • STKH Packaged Foods
  • LSTA Misc Health and Biotechnology Services
  • Sector
  • STKH Consumer Staples
  • LSTA Health Care
  • Exchange
  • STKH Nasdaq
  • LSTA Nasdaq
  • Market Cap
  • STKH 2.7M
  • LSTA 20.9M
  • IPO Year
  • STKH 2021
  • LSTA N/A
  • Fundamental
  • Price
  • STKH $2.75
  • LSTA $2.12
  • Analyst Decision
  • STKH
  • LSTA Strong Buy
  • Analyst Count
  • STKH 0
  • LSTA 2
  • Target Price
  • STKH N/A
  • LSTA $23.50
  • AVG Volume (30 Days)
  • STKH 151.5K
  • LSTA 146.8K
  • Earning Date
  • STKH 11-21-2025
  • LSTA 11-06-2025
  • Dividend Yield
  • STKH N/A
  • LSTA N/A
  • EPS Growth
  • STKH N/A
  • LSTA N/A
  • EPS
  • STKH N/A
  • LSTA N/A
  • Revenue
  • STKH $10,000.00
  • LSTA $1,070,000.00
  • Revenue This Year
  • STKH N/A
  • LSTA N/A
  • Revenue Next Year
  • STKH N/A
  • LSTA N/A
  • P/E Ratio
  • STKH N/A
  • LSTA N/A
  • Revenue Growth
  • STKH N/A
  • LSTA N/A
  • 52 Week Low
  • STKH $2.13
  • LSTA $1.87
  • 52 Week High
  • STKH $104.80
  • LSTA $4.20
  • Technical
  • Relative Strength Index (RSI)
  • STKH 39.47
  • LSTA 40.69
  • Support Level
  • STKH $2.51
  • LSTA $2.04
  • Resistance Level
  • STKH $2.92
  • LSTA $2.20
  • Average True Range (ATR)
  • STKH 0.30
  • LSTA 0.22
  • MACD
  • STKH -0.02
  • LSTA -0.05
  • Stochastic Oscillator
  • STKH 27.83
  • LSTA 22.64

About STKH Steakholder Foods Ltd.

Steakholder Foods Ltd is engaged in transforming the alternative protein industries through its technology. The group specializes in developing and selling 3D-printing production machines, supported by proprietary premix blends, formulated from the highest-quality raw ingredients. These tools help manufacturers of all sizes efficiently produce foods that meet consumer expectations for taste, texture, and appearance and offer a safe and sustainable alternative to industrialized meat and seafood production. The company's expertise in creating alternative protein products replicating traditional meats' complex textures such as beef steaks, white fish, shrimp, and eel. It also explores the integration of cultivated cells, preparing for future advancements in food technology.

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.

Share on Social Networks: